Clinical Trial Update: Adjuvant vs Surgery Only in Early-stage Recurrent NPC [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing adjuvant therapy versus surgery alone for early-stage recurrent nasopharyngeal carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Recurrent Nasopharyngeal Carcinoma | Phase 3 | Status: RECRUITING